Balaxi Pharmaceuticals
21.88
+0.76(+3.60%)
Market Cap₹120.79 Cr
PE Ratio12.35
IndustryHealthcare
Company Performance:
1D+3.60%
1M+15.89%
6M-50.86%
1Y-67.34%
5Y-80.68%
View Company Insightsright
Latest news about Balaxi Pharmaceuticals
Balaxi Pharmaceuticals Soars 22% Amid Major Stake Transfers Mar 05, 2025
Balaxi Pharmaceuticals' stock price surged over 22% in two days following significant ownership changes. Ebisu Global Opportunities Fund and Unico Global Opportunities Fund each acquired approximately 8% stake at ₹53 per share. Simultaneously, MGC Fund Limited and Elala India Opportunities Fund divested their 8% stakes at the same price. The consistent transaction price suggests a mutually agreed valuation. The market responded positively to these bulk deals, reflecting increased investor interest in the company's future prospects.
no imag found